HTA214 Trends Underlying Positive and Negative Decision-Making for New Treatments Targeting Rare Diseases (RD) Appraised by the National Institute for Health and Care Excellence (NICE) in 2023
Abstract
Authors
CA Stothard O Crossley C Knott A Bodke E Samuels M Tang